Aldeyra Therapeutics
Neutralizing Aldehyde Toxicity | Treatment Of Noninfectious Anterior Uveitis And Sjögren-Larsson Syndrome | Aldeyra Therapeutics | Aldeyra Therapeutics. Learn more
Launch date
Employees
Market cap
$369m
Enterprise valuation
$264m (Public information from Sep 2024)
Share price
$5.87 ALDX
Lexington Massachusetts (HQ)
Authorizing premium user...